Brokers  /  Chronos

Chronos

Moderate riskForex / CFD broker
🇺🇸 United States · 2-5 years · since 2023-08-14 · Chronosw Invesment
Unregulated
Visit site ↗
Independent ratingshow third parties score this broker
WikiFX1.41/10
Trustpilot/5
Forex Peace Army/5
🛡️ Been scammed or can’t withdraw from Chronos? Our free assistant writes up your case and shows exactly what to do next →
🇺🇸
No sign that Chronos actively operates in your country (United States). If you were solicited from here, be extra cautious — it may be an unregulated approach or a clone.
46
Moderate risk
Scam Risk Scoremonitored · 2026-07-28
Lower riskHigher risk
  • No verified regulatory license on file
  • No verifiable website or social-media presence
How this score is calculated — view the open algorithm

A transparent weighted score from objective public data — each factor scored 0–100 (higher = riskier), combined by the weights below.

FactorScoreWeight
Regulation & licensing8535%
Company age4515%
Clone / impersonation012%
Withdrawal & exposure complaints012%
Offshore registration108%
Transparency (site/info/social)5310%

Based on public regulatory records, industry databases and independent reviews (Trustpilot, Forex Peace Army). Exit Risk reflects recent negative momentum in real reviews. A risk estimate from public data, not a definitive legal judgment; brokers may request a correction.

Company
Legal nameChronosw Invesment
Headquarters🇺🇸 United States
Founded2023-08-14
Years operating2-5 years
Employees0
Official websitechronoswinvestment.com
Trading conditions
Avg execution speed0 ms
Avg slippage0
Swap rating
Trading cost rating
Monitored traders0
Monitored orders0
Funding & instruments
Deposit methods
Withdrawal methods
Instruments
Registered address
1300 6th Ave, New York, NY 10019, Estados Unidos.

Regulation & licenses · 0

No valid regulatory license found — high caution advised.

Review analysis AI

Chronos Investment, a new unregulated US-based broker, offers a wide range of assets but operates without oversight. The lack of regulatory registration and transparency regarding its operations and account details presents a high risk for traders. We recommend extreme caution and suggest seeking a regulated alternative.

Not for
  • Traders requiring regulatory oversight
Period:

Real user reviews

Similar brokers

What Chronos says about itself as stated by the broker · not independently verified by FXCanary

Target Audience

Chronos Investment states that it seeks to provide a simple and accessible platform for both novice and experienced investors. The broker emphasizes that its services are designed to help users make informed decisions, suggesting a focus on educational support.

Trading Instruments

According to the broker’s promotional material, Chronos Investment offers access to over 250 assets, including company stocks, currencies, commodities, and cryptocurrencies. This diverse range is intended to cater to different investment preferences and strategies.

User Experience

The broker claims to offer a user-friendly interface that simplifies the trading process. Additionally, it highlights the availability of educational resources as a key feature to empower its clients.

About Chronos

Overview

Chronos Investment, operating under the name Chronos, is a US-based investment platform that was founded in August 2023. The company is registered at 1300 6th Ave, New York, NY 10019, United States. According to available information, Chronos positions itself as a straightforward platform aimed at both novice and experienced investors.

The broker claims to offer a wide selection of over 250 tradeable assets, spanning stocks, currencies, commodities, and cryptocurrencies. It also emphasizes the provision of educational resources to assist clients in making informed trading decisions. However, as a relatively new entrant, public information about its operations is limited.

Regulation and Safety

One critical aspect that stands out in our review is the regulatory status of Chronos. Our records indicate that the broker does not hold any known regulatory licences from recognized financial authorities. This lack of regulation is a significant concern for traders who prioritize oversight and protection.

In the United States, retail forex and CFD trading is typically subject to strict regulation by bodies such as the Commodity Futures Trading Commission (CFTC) and the National Futures Association (NFA). The absence of such registrations means that clients trading with Chronos would not benefit from the investor protection schemes and dispute resolution mechanisms that regulated brokers offer.

Platform and Tools

Regarding trading platforms, Chronos has not publicly detailed the specific software it offers. Based on its marketing, the broker aims to provide a user-friendly interface, but concrete information about platform availability (e.g., MetaTrader, proprietary web or mobile platforms) is not readily available.

Similarly, the broker’s educational resources are mentioned but not elaborated upon. Potential traders may find it challenging to assess the quality and depth of these materials without direct access to the broker’s website.

Account Types

There is no public information on the specific account types offered by Chronos. Details such as minimum deposit requirements, spread types, commission structures, or leverage limits are not disclosed. This lack of transparency makes it difficult for traders to compare Chronos with other brokers.

Deposits and Withdrawals

Similarly, funding methods and withdrawal procedures are not specified. Commonly used payment options in the industry include bank transfers, credit/debit cards, and e-wallets, but Chronos has not confirmed which, if any, it supports.

Conclusion

In summary, Chronos Investment is a recently established brokerage with a focus on providing a simple trading experience across multiple asset classes. However, its unregulated status and limited public disclosure present notable risks. Traders are advised to exercise caution and conduct thorough due diligence before considering this platform.

Overview compiled by FXCanary from regulatory records and public data. full Chronos review